Read Larry Connors' blog – Short Term Trading Strategies
Alesco Financial Inc. (NYSE: AFN | Quote | Chart | News | PowerRating) is a publicly owned real estate investment trust. The firm typically invests in real estate and other securities including trust-preferred securities, mortgage backed securities, and corporate loan obligation. Alesco Financial is based in Philadelphia, Pennsylvania. With 59.58 million shares outstanding and 11.35 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of AFN. According to quarterly data provided by the SEC, there were still 59,806 shares of AFN that were failing-to-deliver as of September 28, 2007.
Crystal River Capital Inc. (NYSE: CRZ | Quote | Chart | News | PowerRating) a specialty finance company, engages in the acquisition and origination of a portfolio of commercial and residential real estate structured finance investments. It primarily invests in residential mortgage-backed securities, commercial mortgage-backed securities, whole mortgage loans, bridge loans, B Notes, mezzanine loans, land loans, construction loans, and construction mezzanine loans. The company also invests in direct real estate interests and preferred equity interests in entities that own real estate and diversified asset-backed securities, including aircraft and consumer obligations, and collateralized debt obligations. It would also invest in high yield corporate bonds, investment grade corporate bonds, and related derivatives; government bonds and related derivatives; and other fixed income-related instruments. Hyperion Brookfield Crystal River Capital Advisors, LLC serves as the manager of the company. Crystal River Capital was formed in January 2005 and is based in New York, New York. With 24.77 million shares outstanding and 4.27 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of CRZ. According to quarterly data provided by the SEC, there were still 128,127 shares of CRZ that were failing-to-deliver as of September 28, 2007.
Glimcher Realty Trust (NYSE: GRT | Quote | Chart | News | PowerRating) operates as a real estate investment trust (REIT) in the United States. It owns, leases, acquires, develops, and operates a portfolio of retail properties, including regional and super regional malls, as well as community shopping centers. As of December 31, 2007, the company managed and leased 27 properties, including 23 malls and 4 community centers located in the states of Ohio, West Virginia, California, Florida, North Carolina, Pennsylvania, Kansas, Kentucky, Minnesota, New Jersey, Oklahoma, Oregon, Tennessee, and Washington. Glimcher Realty Trust has elected to be taxed as a REIT and would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders. The company was founded in 1993 and is headquartered in Columbus, Ohio. With 37.79 million shares outstanding and 7.13 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of GRT. According to quarterly data provided by the SEC, there were still 71,205 shares of GRT that were failing-to-deliver as of September 28, 2007.
PIMCO California Municipal Income Fund (NYSE: PCQ | Quote | Chart | News | PowerRating) operates as a nondiversified, closed-end management investment company. It invests primarily in municipal bonds. Allianz Global Investors Fund Management LLC operates as the investment manager of the fund. PIMCO California Municipal Income Fund was founded in 2001 and is based in New York, New York. With 17.96 million shares outstanding and 231,400 shares declared short as of July 2008, there is no longer a failure to deliver in shares of PCQ. According to quarterly data provided by the SEC, there were still 10,059 shares of PCQ that were failing-to-deliver as of September 21, 2007.
The Steak n Shake Company (NYSE: SNS | Quote | Chart | News | PowerRating) engages in the ownership, operation, and franchising of full service, casual dining restaurants in the United States. It primarily serves retailers, housing communities, and businesses. As of September 26, 2007, the company operated 435 company-owned restaurants and 56 franchised restaurants located in 19 states. The Steak n Shake Company was founded in 1934 and is based in Indianapolis, Indiana. With 28.71 million shares outstanding and 6.75 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of SNS. According to quarterly data provided by the SEC, there were still 12,195 shares of SNS that were failing-to-deliver as of September 27, 2007.
ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA | Quote | Chart | News | PowerRating) together with its subsidiaries, discovers and develops medicines to treat cancers by regulating cell signaling with small molecules in the United States and Europe. The company's cancer product candidate includes deforolimus, a potent protein mTOR inhibitor for the treatment of solid tumors, such as sarcomas, hormone refractory prostate cancer, endometrial cancer, brain cancer, and leukemias and lymphomas. It offers Phase 3 clinical trial of oral deforolimus in patients with metastatic soft-tissue and bone sarcomas; and multiple clinical trials of deforolimus, including Phase 2 clinical trials in endometrial, breast, and prostate cancers. The company studies deforolimus as a single agent in multiple Phase 1 and Phase 2 clinical trials in patients with sarcomas, hormone refractory prostate cancer, endometrial cancer, brain cancer, and leukemias and lymphomas. It conducts various multi-center Phase 1b trials of deforolimus in combination with anti-cancer therapies, which focuses on patients with various types of solid tumors; and Phase 1 trials of AP24534 that is used in the treatment of drug-resistant and refractory chronic myeloid leukemia, and hematological cancers. The company licenses NF-kB cell-signaling technology and treatment methods to pharmaceutical and biotechnology companies that conducts research to discover and develop drugs that modulate NF-kB cell-signaling and/or marketing such drugs; and ARGENT cell-signaling regulation technology for various pharmaceutical and biotechnology companies for research and development of therapeutic vaccines, and gene and cell therapy. It has a license agreement with Medinol, Ltd. to develop and commercialize deforolimus-eluting stents and other medical devices to prevent restenosis or reblockage of injured vessels; and collaboration agreement with Merck & Co., Inc. to develop deforolimus. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts. With 69.45 million shares outstanding and 8.32 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of ARIA. According to quarterly data provided by the SEC, there were still 82,229 shares of ARIA that were failing-to-deliver as of September 24, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
